Skip to product information
1 of 1

Scaling Across Species

PK-Sim/OSP-Suite Version 9

Length: 6 Check-Up-Points

Regular price 430,00 €
Regular price Sale price 430,00 €
Sale Sold out
In this series of exercises, you will develop a PBPK model of the sodium/glucose co-transporter 2 inhibitor (SGLT2i) dapagliflozin in pre-clinical species rat, dog, and monkey. You will then translate the models to humans to predict intravenous (iv) administration of dapagliflozin. The hands-on describes the development of a simplified version of the dapagliflozin PBPK model.